Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose simvastatin plus VAD chemotherapy in refractory multiple myeloma
ISRCTN85384018Phase 2Completed
- Sponsor
- University Medical Center Utrecht
- Start
- May 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of simvastatin, vincristine, doxorubicin and dexamethasone, sponsored by University Medical Center Utrecht. Started May 2005; status: completed.
02
Drugs
simvastatinvincristinedoxorubicindexamethasone
Beyond the preview
Go deeper on ISRCTN85384018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN85384018.